Biotech · Private company · Cypress, TX, US

Lucier Pharmaceuticals Inc

Track this companyFree. Adds Lucier Pharmaceuticals Inc to your Dealase workspace and tells you when its record changes.

Clinical trials0None registered

Pipeline programs0None found yet

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

NIH awards1

Diagnostic and Therapeutic Potential of LU-1001 for Coronary Microvascular DysfunctionFiscal year 2026 · $606.3KNIH RePORTER 1R41HL184579-01A1 · fetched Nov 12, 2026